ofloxacin has been researched along with Peritonitis, Tuberculous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maroto Arce, N; Ponce, M | 1 |
| Agarwal, SR; Nandeesh, HP; Saigal, S; Sarin, SK | 1 |
| Delvallez, L; Dequiedt, P; Pagniez, DC; Reade, R; Tacquet, A; Vrtovsnik, F | 1 |
1 review(s) available for ofloxacin and Peritonitis, Tuberculous
| Article | Year |
|---|---|
[Tuberculosis and the digestive tract].
Topics: Adenosine Deaminase; Antitubercular Agents; Ascitic Fluid; Biomarkers; CA-125 Antigen; Chemical and Drug Induced Liver Injury; Diagnostic Imaging; Drug Therapy, Combination; Humans; Intestinal Obstruction; Laparoscopy; Ofloxacin; Peritonitis, Tuberculous; Radiography; Risk Factors; Tuberculin Test; Tuberculosis, Gastrointestinal; Tuberculosis, Pulmonary | 2003 |
1 trial(s) available for ofloxacin and Peritonitis, Tuberculous
| Article | Year |
|---|---|
Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: a preliminary report.
Topics: Adolescent; Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Ofloxacin; Peritonitis, Tuberculous; Risk Factors; Tuberculosis, Gastrointestinal; Tuberculosis, Pulmonary | 2001 |
1 other study(ies) available for ofloxacin and Peritonitis, Tuberculous
| Article | Year |
|---|---|
Ofloxacin treatment may mask tuberculous peritonitis in CAPD patients.
Topics: Aged; Aged, 80 and over; Humans; Male; Ofloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Peritonitis, Tuberculous | 1991 |